Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 9Active not recruiting 3Not yet recruiting 2Completed 2Available 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2

Conditions

Breast Neoplasms 65Neoplasms 50Colorectal Neoplasms 49Prostatic Neoplasms 39Carcinoma, Non-Small-Cell Lung 39Lung Neoplasms 34Pancreatic Neoplasms 27Leukemia, Myeloid, Acute 23Multiple Myeloma 21Recurrence 17Carcinoma, Hepatocellular 17Uterine Cervical Neoplasms 16Ovarian Neoplasms 15Neoplasm Metastasis 14Squamous Cell Carcinoma of Head and Neck 13Head and Neck Neoplasms 13Triple Negative Breast Neoplasms 12Stomach Neoplasms 12Melanoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Glioblastoma 11Endometrial Neoplasms 11Rectal Neoplasms 10Carcinoma, Renal Cell 10Brain Neoplasms 10Advanced Solid Tumors 10Lymphoma, B-Cell 9Disease 9Colonic Neoplasms 9Esophageal Neoplasms 8

Interventions

Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Gastrointestinal Stromal Tumors × 30 days × Clear all
NCT07618377 2026-06-01

Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments

Ono Pharmaceutical Co., Ltd.

Phase 1 Not yet recruiting
10 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT07585266 2026-05-13

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

GlaxoSmithKline

Phase 3 Not yet recruiting
800 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡